There have been no reports of illness, however, the bacteria could cause serious infections for individuals with a compromised immune system, or those with chronic lung conditions, such as cystic fibrosis. B. cepacia poses little medical risk to healthy individuals.
P&G detected this problem during routine quality control at the plant and promptly took action. The company's analysis to date shows this problem is limited to a single batch of raw material mixture involving three lots of product. These three lots were sold only in the United States, Germany and the United Kingdom.
The lot numbers of the products involved are:
9239028831 United States Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist, 15 ml., Nasal Spray
9224028832 United Kingdom Vicks Sinex Micromist Aqueous Nasal Spray Solution, 15 ml
9224028833 Germany Wick Sinex Schnupfenspray Dosiersystem, 15 ml
P&G is removing the product in question from store shelves and has informed regulatory authorities in the affected countries. P&G said it found the bacteria B. cepacia in a small amount of product from U.S. lot 9239028831 and is conducting testing on the U.K. and German lots that have been produced from the same batch of raw material mixture.
Anyone who has these specific lots of this product can call P&G for a replacement coupon or refund at the following numbers:
From the United States, please call: 1.877.876.7881 (Hours of operation: Monday – Friday, 9AM – 6PM US ET, Saturday – Sunday, 9AM – 4PM US ET)
From the United Kingdom, please call: 0800.5555.15 (Hours of operation: 19 November, 4PM – 9PM local time and will continue Monday – Friday, 8AM – 6PM local time, Saturday – Sunday, 9AM – 5PM local time)
Cheryl Phillips
HULIQ.com
source: www.vicks.com
Posted November 19th, 2009 by Cheryl Phillips
